GS-621763 is a prodrug of the antiviral nucleoside GS-441524, demonstrating efficacy against SARS-CoV-2. It has shown promising antiviral activity in both in vitro cellular assays and in vivo models of COVID-19 pathogenesis, supporting its investigation as a research tool for coronavirus therapeutics.